Back to Trades
Regnante Keith
Chief Financial OfficerCIK 0001682068
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Regnante Keith, Chief Financial Officer, has disclosed $0 in transactions — all concentrated in CITY THERAPEUTICS, INC. (CTY). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Oct 15 | CTY CITY THERAPEUTICS, INC. | Regnante Keith | Chief Financial Officer | Other | $0 |
1 filing